These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28494927)

  • 21. The effect of bovine vaccines against respiratory viruses administered either intranasal or intramuscular on broncho-alveolar fluid cells of heifers.
    Rossi PS; Mattei RI; Schllemer NR; Thomaz GR; Antunes AV; Virmond MP; Taube MJ; Bertagnon HG
    Vet Q; 2021 Dec; 41(1):97-106. PubMed ID: 33375918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A live bovine herpesvirus-1 marker vaccine is not shed after intramuscular vaccination.
    Makoschey B; Beer M
    Berl Munch Tierarztl Wochenschr; 2007; 120(11-12):480-2. PubMed ID: 18085158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal booster vaccination of beef steers reduces clinical signs following experimental coinfection with BRSV and BHV-1 without reducing shedding of BRD-associated bacteria.
    Martínez DA; Chamorro MF; Passler T; Huber L; Falkenberg S; Walz PH; Thoresen M; Raithel G; Silvis S; Dimitrov KM; Stockler R; Woolums AR
    Am J Vet Res; 2024 May; 85(5):. PubMed ID: 38422620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host.
    Gao Y; Leary TP; Eskra L; Splitter GA
    Vaccine; 1994 Feb; 12(2):145-52. PubMed ID: 8147097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD.
    Gogev S; Vanderheijden N; Lemaire M; Schynts F; D'Offay J; Deprez I; Adam M; Eloit M; Thiry E
    Vaccine; 2002 Jan; 20(9-10):1451-65. PubMed ID: 11818166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant virus-expressed bovine cytokines do not improve efficacy of a bovine herpesvirus 1 marker vaccine strain.
    König P; Beer M; Makoschey B; Teifke JP; Polster U; Giesow K; Keil GM
    Vaccine; 2003 Dec; 22(2):202-12. PubMed ID: 14615147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody responses by cattle after vaccination with commercial viral vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens and subsequent revaccination at day 140.
    Fulton RW; Confer AW; Burge LJ; Perino LJ; d'Offay JM; Payton ME; Mock RE
    Vaccine; 1995; 13(8):725-33. PubMed ID: 7483787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study on latency in calves by five vaccines against bovine herpesvirus-1 infection.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Dico ML; Rotola A; Sardonini Q; Petrini S; Cassai E
    Comp Immunol Microbiol Infect Dis; 2002 Jul; 25(4):205-15. PubMed ID: 12135235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection.
    Jericho KW; Yates WD; Babiuk LA
    Am J Vet Res; 1982 Oct; 43(10):1776-80. PubMed ID: 6183996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of a quadrivalent vaccine against respiratory diseases caused by BHV-1, PI3V, BVDV and BRSV in experimentally infected calves.
    Salt JS; Thevasagayam SJ; Wiseman A; Peters AR
    Vet J; 2007 Nov; 174(3):616-26. PubMed ID: 17276108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of ambient temperature on viral replication and serum antibody titers following administration of a commercial intranasal modified-live infectious bovine rhinotracheitis-parainfluenza-3 virus vaccine to beef cattle housed in high- and moderate-ambient temperature environments.
    Grissett GP; White BJ; Anderson DE; Larson RE; Miesner MD
    Am J Vet Res; 2014 Dec; 75(12):1076-82. PubMed ID: 25419807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol.
    Van Donkersgoed J; McCartney D; van Drunen Littel-van den Hurk S
    Can J Vet Res; 1996 Jan; 60(1):55-8. PubMed ID: 8825995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV.
    Taylor G; Rijsewijk FA; Thomas LH; Wyld SG; Gaddum RM; Cook RS; Morrison WI; Hensen E; van Oirschot JT; Keil G
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1759-67. PubMed ID: 9680140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a temperature-sensitive modified-live bovine herpesvirus type-1 vaccine against abortion and stillbirth in pregnant heifers.
    Cravens RL; Ellsworth MA; Sorensen CD; White AK
    J Am Vet Med Assoc; 1996 Jun; 208(12):2031-4. PubMed ID: 8707679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BHV-1 glycoprotein 1 and recombinant interleukin 1 beta efficiently elicit mucosal IgA response.
    Gao Y; Daley MJ; Splitter GA
    Vaccine; 1995 Jun; 13(9):871-7. PubMed ID: 7483811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of dose, route and virulence of bovine herpesvirus 1 vaccine on experimental respiratory disease in cattle.
    Jericho KW; Babiuk LA
    Can J Comp Med; 1983 Apr; 47(2):133-9. PubMed ID: 6309347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response to infectious bovine rhinotracheitis virus (IBRV) following natural infection or vaccination by intranasally or parenterally administered vaccines.
    Todd JD
    Dev Biol Stand; 1975; 28():526-9. PubMed ID: 165128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bovine herpes virus infections in cattle.
    Nandi S; Kumar M; Manohar M; Chauhan RS
    Anim Health Res Rev; 2009 Jun; 10(1):85-98. PubMed ID: 19558751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination of calves against bovine herpesvirus-1: assessment of the protective value of eight vaccines.
    Castrucci G; Frigeri F; Salvatori D; Ferrari M; Sardonini Q; Cassai E; Lo DM; Rotola A; Angelini R
    Comp Immunol Microbiol Infect Dis; 2002 Jan; 25(1):29-41. PubMed ID: 11831745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.